Technical Articles
superagonist
Where IL-15 Sits in the Cell-Therapy Pipeline: Four Translational Routes and Their Evidence
IL-15 supports NK and T-cell therapy programs through four translational routes: ex vivo expansion, in vivo persistence, IL-15Ralpha-Fc fusions and superagonists.
View details
- Immunity/Inflamma
- IL-15
- cell therapy
- NK cell
- IL-15Ralpha-Fc
- superagonist
- memory T cell
- UA040010
- 1






